Pharmabiz

Cytiva and Veeda Lifesciences drive biopharma innovation with new host cell protein services center

Cytiva and Veeda Lifesciences drive biopharma innovation with new host cell protein services center: Our Bureau, Bengaluru ...
Le Lézard

The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma

On November 25, 2025, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced ...
Le Lézard

/C O R R E C T I O N -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd./

Recently, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or ...

Palampur varsity empowers students with cutting-edge DNA tech training

Chaudhary Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya, Palampur, successfully concluded a two-day workshop on ...

China's First Domestic IL-23p19 Monoclonal Antibody: Innovent's PECONDLE® (Picankibart Injection) Received NMPA Approval

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...